miRNA delivery via nanowires restores functional responses in aged T cells
- 1Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA
- 2Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA 30332, USA
- 3Winship Cancer Center, Emory School of Medicine, Emory University, Atlanta, GA 30322, USA
Abstract
SUMMARY: Aging reshapes CD8+ T cell immunity by depleting naive populations, narrowing repertoire diversity, and promoting dysfunctional states, thereby weakening responses to infection or vaccination. This study presents a polyethyleneimine (PEI)-functionalized silicon nanowire platform for high-viability, non-viral delivery of single or multiplexed microRNAs (miRNAs) into resting aged CD8+ T cells. Nanowires enable transient modulation of transcriptional programs governing T cell activation, metabolism, proliferation, and differentiation. Delivering a single miRNA influences early activation and differentiation stages, while multiplexed miRNA delivery leads to a broader boost in activation responses, effector functions, metabolic health, and cell proliferation. In vivo, ex vivo-treated aged CD8+ T cells exhibit enhanced early effector priming following antigen exposure. Similarly, in aged human CD8+ T cells, multiplexed miRNA enhances activation and cytotoxic responses and sustains an effector-primed state during early activation and expansion. This method consistently improves function across donors aged from healthy individuals to those with current or past cancer.
Related
- Tissue-Specific miRNA Responses to Tick-Borne Encephalitis Virus Strains in Mice
- Phosphorylation of spleen tyrosine kinase Y130 positively regulates intracellular signaling and functional responses in platelets
- Split-intein-mediated engineering of VSV-G-free extracellular vesicles for enhanced cargo loading and delivery of functional proteins
- Next-Generation Functional Nanoplatforms: Engineering Plant-Derived Extracellular Vesicles for Targeted Bioactive Delivery and Health Applications
- GW182 Proteins Directly Recruit Cytoplasmic Deadenylase Complexes to miRNA Targets
BibTeX
@article{dai2026mirna,
title = {{miRNA delivery via nanowires restores functional responses in aged T cells}},
author = {Zhonghao Dai and Shaylyn Grier and Zhe Zhong and Ameya Dravid and Joscelyn Mejías and Jean L. Koff and Andrés J. García and Ankur Singh},
journal = {Cell biomaterials},
year = {2026},
month = jul,
doi = {10.1016/j.celbio.2026.100514},
url = {https://europepmc.org/article/PMC/PMC13730167},
note = {CC BY},
}
RIS
TY - JOUR
TI - miRNA delivery via nanowires restores functional responses in aged T cells
AU - Zhonghao Dai
AU - Shaylyn Grier
AU - Zhe Zhong
AU - Ameya Dravid
AU - Joscelyn Mejías
AU - Jean L. Koff
AU - Andrés J. García
AU - Ankur Singh
PY - 2026
DA - 2026/07/03
JO - Cell biomaterials
DO - 10.1016/j.celbio.2026.100514
UR - https://europepmc.org/article/PMC/PMC13730167
AB - SUMMARY: Aging reshapes CD8+ T cell immunity by depleting naive populations, narrowing repertoire diversity, and promoting dysfunctional states, thereby weakening responses to infection or vaccination. This study presents a polyethyleneimine (PEI)-functionalized silicon nanowire platform for high-viability, non-viral delivery of single or multiplexed microRNAs (miRNAs) into resting aged CD8+ T cells. Nanowires enable transient modulation of transcriptional programs governing T cell activation, metabolism, proliferation, and differentiation. Delivering a single miRNA influences early activation and differentiation stages, while multiplexed miRNA delivery leads to a broader boost in activation responses, effector functions, metabolic health, and cell proliferation. In vivo, ex vivo-treated aged CD8+ T cells exhibit enhanced early effector priming following antigen exposure. Similarly, in aged human CD8+ T cells, multiplexed miRNA enhances activation and cytotoxic responses and sustains an effector-primed state during early activation and expansion. This method consistently improves function across donors aged from healthy individuals to those with current or past cancer.
SN - 3050-5623
ER -